Syncope in the Patient with Nonischemic Dilated Cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 1, 2004, Pages 97-100

  Singh, Sushil K ^a   Link, Mark S ^a   Wang, Paul J ^a   Homoud, Munther ^a   Estes III, N A Mark ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; ELECTROPHYSIOLOGY; HEART ASSIST DEVICE; HEART MUSCLE ISCHEMIA; HISTORY OF MEDICINE; HUMAN; IMPLANTATION; INCIDENCE; PATHOGENESIS; REVIEW; SUDDEN DEATH; SYNCOPE;

CARDIOMYOPATHY, DILATED; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; PROGNOSIS; SYNCOPE;

EID: 1642479875     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00393.x     Document Type: Review

References (21)

1. Middlekauff HR, Stevenson WG, Stevenson LW, et al. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 1993; 21:110-116.
2. Tchou PJ, Krebs AC, Sra J, et al. Syncope: A warning sign in idiopathic dilated cardiomyopathy patients. (abstract) J Am Coll Cardiol 1991; 17(Suppl. A):196A.
3. Brembilla-Perrot, Donetti J, Terrier de la Chaise A, et al. Diagnostic value of ventricular stimulation in patients with idopathic dilated cardiomyopathy. Am Heart J 1991; 121:1124-1131.
4. Fruhwald FM, Eber B, Schumacher M, et al. Syncope in dilated cardiomyopathy is a predictor of sudden cardiac death. Cardiology 1996; 87:177-180.
5. Poll DS, Marchlinski FE, Buxton AE, et al. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986; 58:992-997.
6. Kadish A, Schmaltz S, Calkins H, et al. Management of nonsustained ventricular tachycardia guided by electrophysilogic testing. PACE 1993; 16:1037-1050.
7. Turitto G, Ahuja RK, Caref EB, et al. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: Role of programmed ventriuclar stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol 1994; 24:1523-1528.
8. Hsia H, Marchlinski F. Electrophysiology studies in patients with dilated cardiomyopathies. Cardiac Electrophysiol Rev 2002, 6:472-481.
9. Knight BP, Goyal R, Pelosi F, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999; 33:1964-1970.
10. Russo AM, Verdino R, Schorr C, et al. Occurrence of implantable defibrillator events in patients with syncope and nonischemic dilated cardiomyopathy. Am J Cardiol 2001; 88:1444-1446.
11. Fonarow G, Feliciano Z, Boyle N, et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol 2001; 85:981-985.
12. Kuck K, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest; The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102:748-754.
13. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
14. Steinberg J, Beckman K, Greene HL, et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: Analysis of the AVID registry and an AVID substudy. J Cardiovasc Electrophysiol 2001; 12:996-1001.
15. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the defibrillator against amiodarone. Circulation 2000; 101:1297-1302.
16. Saeed M, Saba S, Swygman C, et al. High risk of ventricular arrhythmia in long term follow-up of patients with idiopathic dilated cardiomyopathy and unexplained syncope. (abstract) Circulation 2000; 102:1809.
17. Brilakis ES, Shen W, Hammill S, et al. Role of programmed ventricular stimulation and implantable cardioverter-defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. PACE 2001; 24:1623-1630.
18. Rankovic V, Karha J, Passman R, et al. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2002; 89:1072-1076.
19. Grimm W, Hoffman J, Muller H, et al. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol 2002; 39:780-787.
20. Cappato R, Negroni S, Bentivegna S, et al. Role of implantable cardioverter defibrillators in dilated cardiomyopathy. J Cardiovasc Electrophysiol 2002; 13(Supp.):S106-109.
21. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106:2145-2161.